Joel Brooks
Pediatric Allergy/Immunology · New York, NYNPI 1629400635
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,370 of the $13,479 with a category attached, or 62.1%. 21 manufacturers reported payments, led by AstraZeneca at 27.7% of the total.
Across 190 payments — averaging $70.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$4K
- Sanofi$3K
- Dermavant Sciences, Inc.$2K
- CSL Behring$943
- Biocryst US Sales Co., LLC$621
- Pharming Healthcare, Inc.$419
- plus $2K from 15 others
What the payments were for
- Consulting fees$3,71928%
- Travel & lodging$1,39010%
- Food & beverage$8,37062%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 38 | $3,738 |
| Sanofi | 33 | $3,319 |
| Dermavant Sciences, Inc. | 5 | $2,367 |
| CSL Behring | 34 | $943 |
| Biocryst US Sales Co., LLC | 14 | $621 |
| Pharming Healthcare, Inc. | 6 | $419 |
| Organon | 8 | $405 |
| ARS Pharmaceuticals Operations, Inc. | 9 | $279 |
| Novartis | 11 | $231 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $200 |
| Alk-abello, Inc | 2 | $168 |
| Sanofi-aventis U.S. LLC | 1 | $148 |
| GSK | 6 | $142 |
| Kaleo, Inc. | 5 | $122 |
| Lilly USA, LLC | 1 | $114 |
| Biocryst Pharmaceuticals, Inc. | 1 | $98 |
| Amgen | 4 | $77 |
| Aimmune Therapeutics, Inc. | 1 | $28 |
| Ultragenyx Pharmaceutical Inc. | 1 | $25 |
| Phadia US Inc. | 1 | $20 |
| Novo Nordisk | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,479 in reported general payments places this provider in the 80th percentile of 51 pediatric allergy/immunology providers in New York.
See all pediatric allergy/immunology providers in New York →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 20 | $75,650 |
| XolairOmalizumab | 20 | $63,517 |
| Fluticasone Propionate | 13 | $134 |
Paid to pharmacies, not to this prescriber.
Other pediatric allergy/immunology in New York
- Jordan OrangeNew York$203K
- Anna Nowak-WegrzynNew York$74K
- Ramsay FuleihanNew York$68K
- Wayne ShrefflerNew York$52K
- Julie WangNew York$14K
- Hugh SampsonNew York$8K
- Jacob KattanNew York$6K
- Nicole RamseyNew York$5K
- Amanda CoxNew York$3K
- Lisa MorenoNew York$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.